These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32263750)

  • 1. Delivery of an active lysosomal enzyme using GNeosomes.
    Hamill KM; Wexselblatt E; Tong W; Esko JD; Tor Y
    J Mater Chem B; 2016 Sep; 4(35):5794-5797. PubMed ID: 32263750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GNeosomes: Highly Lysosomotropic Nanoassemblies for Lysosomal Delivery.
    Wexselblatt E; Esko JD; Tor Y
    ACS Nano; 2015; 9(4):3961-8. PubMed ID: 25831231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of Cargo to Lysosomes Using GNeosomes.
    Hamill KM; Wexselblatt E; Tong W; Esko JD; Tor Y
    Methods Mol Biol; 2017; 1594():151-163. PubMed ID: 28456981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Glycoengineered Enzyme with Multiple Mannose-6-Phosphates Is Internalized into Diseased Cells to Restore Its Activity in Lysosomes.
    Hyun JY; Kim S; Lee HS; Shin I
    Cell Chem Biol; 2018 Oct; 25(10):1255-1267.e8. PubMed ID: 30146240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery using polyhistidine peptide-modified liposomes that target endogenous lysosome.
    Hayashi T; Shinagawa M; Kawano T; Iwasaki T
    Biochem Biophys Res Commun; 2018 Jun; 501(3):648-653. PubMed ID: 29746864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats.
    Gregoriadis G; Ryman BE
    Biochem J; 1972 Aug; 129(1):123-33. PubMed ID: 4646772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Response of Liposomes Modified with Lysosomal Membrane Proteins to the Targeting Ability Associated with Antimicrobial Activity.
    Bang SH; Park RM; Sekhon SS; Lee GW; Kim YH; Min J
    J Biomed Nanotechnol; 2018 Dec; 14(12):2198-2207. PubMed ID: 30305226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells.
    Weissmann G; Bloomgarden D; Kaplan R; Cohen C; Hoffstein S; Collins T; Gotlieb A; Nagle D
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):88-92. PubMed ID: 1054517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of liposomes to hepatocytes.
    Ghosh PC; Bachhawat BK
    Targeted Diagn Ther; 1991; 4():87-103. PubMed ID: 1724610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of liposome-sequestered hydrophobic proteins to lysosomes of normal and Batten disease cells.
    Ansari NH; He Q; Cook JD; Wen J; Srivastava SK
    J Neurosci Res; 1997 Feb; 47(3):341-7. PubMed ID: 9039656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol and lysosomal stability in normal and atheromatous rats.
    Philip B; Kurup PA
    Atherosclerosis; 1977 Jun; 27(2):129-39. PubMed ID: 901614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis.
    Muro S; Schuchman EH; Muzykantov VR
    Mol Ther; 2006 Jan; 13(1):135-41. PubMed ID: 16153895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer.
    Zhang Y; Wang Y; Boado RJ; Pardridge WM
    Pharm Res; 2008 Feb; 25(2):400-6. PubMed ID: 17602284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal phospholipase activity is decreased in mucolipidosis II and III fibroblasts.
    Jansen SM; Groener JE; Poorthuis BJ
    Biochim Biophys Acta; 1999 Jan; 1436(3):363-9. PubMed ID: 9989267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Advanced Strategies for the Treatment of Lysosomal Diseases Affecting the Central Nervous System.
    Gigliobianco MR; Di Martino P; Deng S; Casadidio C; Censi R
    Curr Pharm Des; 2019; 25(17):1933-1950. PubMed ID: 31566121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-Si-rhodamines: A new class of two-photon fluorescent dyes with intrinsic targeting ability for lysosomes.
    Zhang H; Liu J; Wang L; Sun M; Yan X; Wang J; Guo JP; Guo W
    Biomaterials; 2018 Mar; 158():10-22. PubMed ID: 29272765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal localization of enzyme-containing liposomes injected into rats.
    Gregoriadis G; Ryman BE
    Biochem J; 1972 Jul; 128(4):142P-143P. PubMed ID: 4638786
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma hyaluronidase activity in mucolipidoses II and III: marked differences from other lysosomal enzymes.
    Natowicz MR; Wang Y
    Am J Med Genet; 1996 Oct; 65(3):209-12. PubMed ID: 9240745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
    Gao J; Ochyl LJ; Yang E; Moon JJ
    Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.